Document is current
Any future updates will be listed below
-
Authors
Jimenez-Sanchez, Sofia
Maksoud, Rebekah
Eaton-Fitch, Natalie
Marshall-Gradisnik, Sonya
Broadley, Simon A.
-
Funding
Funding for this research was provided by:
Multiple Sclerosis Australia (22-3-052, 21-2-060)
- License Information
-
More Information
Article History
Received: 10 July 2024
Accepted: 17 October 2024
First Online: 1 November 2024
Declarations
:
: This systematic review utilised existing published data and did not directly involve the recruitment of participants therefore no consent was required. The authors also advise that there are no other ethical conflicts relating to this research project to disclose.
: Not applicable.
: The authors wish to declare that SJS and SAB are investigators on the RAMBLE trial (ACTRN12621001502820). The RAMBLE study has been funded by MS Australia (Project Grant 21-2-060). SAB has received support through Griffith University in relation to service on advisory boards, conference organising committees and speakers honoraria from Novartis, Roche and Alexion, and has been a principal investigator on clinical trials sponsored by ATARA, Biogen-Idec, Sanofi and UCB. RM, NEF, and SMG declare no conflicts of interest.
